Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows

IF 5.6 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

mAbs Pub Date : 2024-02-21 DOI:10.1080/19420862.2024.2311992

Caitlin Fawcett, Joseph. R. Tickle, Charlotte. H. Coles

引用次数: 0

Abstract

A major driver for the recent investment surge in bispecific antibody (bsAb) platforms and products is the multitude of distinct mechanisms of action that bsAbs offer compared to a combination of t...

查看原文本刊更多论文

促进高通量双特异性抗体的生产以及在生物制药发现工作流程中的潜在应用

最近，双特异性抗体（bsAb）平台和产品的投资激增，其主要驱动因素是，双特异性抗体（bsAb）具有多种不同的作用机制，而bsAb平台和产品的作用机制则不同于...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

mAbs 工程技术-仪器仪表

CiteScore

10.70

自引率

11.30%

发文量

审稿时长

6-12 weeks

期刊介绍： mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus, but also strives to serve a broader readership. The articles are thus of interest to scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.